Andrew Lukowiak, Ph.D., President and Chief Scientific Officer
Andrew Lukowiak, Ph.D., has served as CSO since December 2021.
Andrew Lukowiak has over 20 years of management experience in the molecular diagnostics and life sciences industries. Prior to joining Epigenomics, Mr. Lukowiak served as CEO and Board Member for Millennium Health, a leading specialty toxicology laboratory. He was also COO of AltheaDx Inc., where he led the development, validation and launch of multiple Real-Time PCR tests for a broad array of disease states. Additionally, Mr. Lukowiak was a senior R&D executive at GenMark Diagnostics and Hologic, where he was responsible for both PMA and 510(k) cleared products including the support and automation of an HPV test for cervical cancer. Mr. Lukowiak earned his Ph.D. degree in Genetics from the University of Georgia and his Bachelor of Science in Biology from Pennsylvania State University.